A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

June 2, 2021

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions
Alzheimer Disease
Interventions
DRUG

Sodium Oligomannate Capsules

Sodium Oligomannate Capsules, each capsule contains 150 mg of sodium oligomannate. The recommended treatment is oral administration, 450 mg (3 capsules) per dose, bid, in morning and evening.

Trial Locations (63)

Unknown

Anhui Mental Health Center, Hefei

The First Affiliated Hospital of USTC(Anhui Provincial Hospital), Hefei

Beijing Bo'ai Hospital, Beijing

Beijing Geriatric Hospital, Beijing

Beijing Luhe Hospital, Capital Medical University, Beijing

Dongfang Hospital Beijing University of Chinese Medicine, Beijing

Sanbo Brain Hospital Capital Medical University, Beijing

Chongqing 11th People's Hospital (Chongqing Special Care Hospital), Chongqing

Xiamen Xianyue Hospital, Xianmencun

Dongguan People's Hospital, Dongguan

Red Cross Hospital of Guangzhou, Guangzhou

The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou

Zhujiang Hospital, Southern Medical University, Guangzhou

Shenzhen Luohu District People's Hospital, Shenzhen

Shenzhen Second People's Hospital (The First Affiliated Hospital of Shenzhen University), Shenzhen

Zhuhai People's Hospital, Zhuhai

Guihang Guiyang Hospital, Guiyang

Second People's Hospital of Guizhou Province, Guiyang

The First Affiliated Hospital of Guizhou University of Chinese Medicine, Guiyang

The Second Affiliated Hospital of Guizhou University of Chinese Medicine, Guiyang

Hebei Petro China Central Hospital, Langfang

General Hospital of North China Petroleum Administration (North China Hospital Affiliated to University of Chinese Academy of Sciences), Renqiu

Wuhan Central Hospital, Wuhan

Wuhan Mental Health Center, Wuhan

Lianyungang Chinese Medicine Hospital, Lianyungang

The First People's Hospital of Lianyungang, Lianyungang

Nanjing First Hospital, Nanjing

Nantong No.1 People's Hospital, Nantong

Changshu No.2 People's Hospital, Suzhou

Suzhou Guangji Hospital, Suzhou

Suzhou Municipal Hospital(Geriatrics), Suzhou

Suzhou Municipal Hospital, Suzhou

Suzhou Ninth People's Hospital, Suzhou

Taizhou Second People's Hospital, Taizhou

Affiliated Hospital of Jiangsu University, Zhenjiang

Zhenjiang mental health center, Zhenjiang

Jinan Central Hospital Affiliated To Shandong University, Jinan

Shandong Mental Health Center, Jinan

Affiliated Hospital of Jining Medical University, Jining

Liaocheng People's Hospital, Liaocheng

Weifang People's Hospital, Weifang

Huashan Hospital affiliated to Fudan University, Shanghai

Shanghai East Hospital, Shanghai

Shanghai Fengxian District Central Hospital, Shanghai

Shanghai Fifth People's Hospital,Fudan University, Shanghai

Shanghai Pudong New Area People's Hospital, Shanghai

Tong Ren Hospital,Shanghai Jiao Tong University School Of Medicine, Shanghai

Second hospital of Shanxi Medical University, Taiyuan

Shanxi Bethune Hospital, Taiyuan

Shanxi Provincial People's Hospital, Xi’an

Xi 'an Baoshihua Changqing Hospital, Xi’an

Xi'an Central Hospital, Xi’an

Chengdu Eighth People's Hospital, Chengdu

Sichuan Academy of Medical Sciences sichuan Provincial People's Hospital, Chengdu

Sichuan Baoshihua Hospital, Chengdu

Chengdu Fourth People's Hospital, Chengdu

The Fifth People's Hospital of Chengdu, Chengdu

Nanchong Central Hospital, Nanchong

Huzhou Third Municipal Hospital, Huzhou

Huamei Hospital,University of Chinese Academy of Sciences, Ningbo

Ningbo First Hospital, Ningbo

Ningbo Kangning Hospital, Ningbo

Wenzhou People's Hospital, Wenzhou

All Listed Sponsors
lead

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

INDUSTRY